Russia has announced a groundbreaking development in cancer treatment with the creation of an mRNA-based vaccine designed to treat cancer patients. This revolutionary vaccine, set to be launched in early 2025, will be distributed free of cost to Russian citizens, according to state-run media reports.
The personalised vaccine, which uses genetic material derived from a patient’s tumour, will cost the state approximately 300,000 rubles (USD 2,869) per dose. The announcement was made by Andrey Kaprin, head of the Radiology Medical Research Centre of the Ministry of Health. "This vaccine aims to treat cancer patients rather than prevent tumour formation,” Kaprin stated.
Source & Credit :- Business Today